A2 Biotherapeutics, Inc. | $80,000,000 | (Jan 10, 2025)
Prudentia Sciences | $7,000,000 | (Jan 10, 2025)
Certified by Founder
Lodge
RLTYco
start up
United States
- New York, New York
- 10/01/2025
- Series A
- $20,000,000
"RLTY offers a platform that allows agents to access their commission upfront to reinvest in themselves and their business. As an agent-first company and one that is dedicated to helping the industry modernize with new tech solutions, we are proud to partner with RLTY to deliver a smart and practical solution to NY real estate agents.” – Ryan Serhant, a Partner at RLTY and CEO+Founder of SERHANT.”
- Industry Financial Services
- Website https://rltyco.com/
- LinkedIn https://www.linkedin.com/company/rlty-co/
Air | $35,000,000 | (Jan 10, 2025)
Biosphere | $8,800,000 | (Jan 10, 2025)
RyboDyn Inc. | $4,000,000 | (Jan 10, 2025)
Abstract(US) | $4,800,000 | (Jan 10, 2025)
PrettyDamnQuick | $25,000,000 | (Jan 10, 2025)
Oxford Cancer Analytics | $11,000,000 | (Jan 10, 2025)
UNLISTED | $2,250,000 | (Jan 9, 2025)
Zeto / Rapid Full-Montage EEG | $31,000,000 | (Jan 9, 2025)
Red Rover Health, Inc. | $4,000,000 | (Jan 9, 2025)